Home » Reports » Broker Ratings » Circassia Pharmaceuticals PLC 10.3% Potential Upside Indicated by JP Morgan Cazenove
broker ratings

Circassia Pharmaceuticals PLC 10.3% Potential Upside Indicated by JP Morgan Cazenove

Circassia Pharmaceuticals PLC using EPIC/TICKER code (LON:CIR) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘NEUTRAL’ this morning by analysts at JP Morgan Cazenove. Circassia Pharmaceuticals PLC are listed in the Health Care sector within UK Main Market. JP Morgan Cazenove have set a target price of 100 GBX on its stock. This is indicating the analyst believes there is a potential upside of 10.3% from the opening price of 90.7 GBX. Over the last 30 and 90 trading days the company share price has decreased 1.3 points and decreased 9.2 points respectively. The 52 week high share price is 115.61 GBX while the 52 week low for the share price is 76.75 GBX.

Circassia Pharmaceuticals PLC has a 50 day moving average of 91.68 GBX and the 200 Day Moving Average price is recorded at 92.21. There are currently 333,466,242 shares in issue with the average daily volume traded being 163,702. Market capitalisation for LON:CIR is £308,306,220 GBP.